首页> 外文期刊>Journal of optoelectronics and advanced materials >Review of the role played by the photosensitizer's photobleaching during photodynamic therapy
【24h】

Review of the role played by the photosensitizer's photobleaching during photodynamic therapy

机译:回顾光动力疗法中光敏剂的光漂白作用

获取原文
获取原文并翻译 | 示例
           

摘要

Photodynamic therapy (PDT) is based on the combined administration of photosensitizing drugs and light to treat a variety of malignant, pre-malignant and also non-malignant diseases. The reactive species resulting from the excitation of the photosensitizers are at the origin of their photodegradation, which has an influence on the treatment outcome. PDT has a long history, including the improvements of photosensitizers and light delivery systems, which led to approved clinical applications. A knowledge of the photobleaching processes occurring during PDT will help implicit dosimetry, as it describes multiple photophysical, photochemical and photobiological factors involved in PDT. Due to this the clinical efficacy of PDT and optimisation of treatment regimes will be allowed.
机译:光动力疗法(PDT)基于光敏药物和光的联合给药,可治疗各种恶性,恶性前和非恶性疾病。由光敏剂的激发产生的反应性物质是其光降解的起点,这对处理结果有影响。 PDT拥有悠久的历史,包括对光敏剂和光传输系统的改进,导致了批准的临床应用。了解PDT期间发生的光漂白过程将有助于隐式剂量测定,因为它描述了PDT中涉及的多种光物理,光化学和光生物学因素。因此,PDT的临床疗效和治疗方案的优化将被允许。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号